To facilitate a conversation with members of the multi-disciplinary team that is responsible for the compassionate and respectful process of taking care of decedents including transporting them from the unit to the morgue, to facilitate viewings for families, and discharging to funeral homes or the ME office. To describe, and reflect on the meaning, and the importance of providing this service to families while taking into consideration legal and regulatory implications. 

Objectives

After participating in this educational activity, attendees should be able to:
1|Discuss the indications for use of GLP1s
2|Identify the risks involved with the use of GLP1s
3|Summarize the various challenges faced by both providers and patients

Presenter(s): 

Facilitator:
Reva Kleppel, Clinical Research Manager
Clinical Research Manager

Panelists:

Dr. Cecilia Lozier, Chief of Endocrinology
Dr. Phyllis Owuzu-Griffin, Medical Director of West Side Adult Medicine
Nicole Knee, Clinical Dietitian
Patient:  Richard Podgurski
 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Reva Kleppel, MSW, MPHSpeakerNo relevant relationships with ineligible companies to discloseNo
Dr. Cecilia LozierPanelistNo relevant relationships with ineligible companies to discloseNo
Dr. Phyllis Owuzu-GriffinPanelistNo relevant relationships with ineligible companies to discloseNo
Nicole KneePanelistNo relevant relationships with ineligible companies to disclose No
Richard PodgurskliPanelistNo relevant relationships with ineligible companies to discloseNo
Session date: 
04/14/2025 - 12:00pm to 1:00pm EDT
Location: 
Baystate Medical Center
759 Chestnut Street
Chestnut Conference Center 1 & 2 and Webinar
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Risk Management
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.